Growth hormone secretagogue receptor antagonists

Expert Opinion on Therapeutic Patents

Volumn 22, Issue 6, 2012, Pages 697-700

  Costantino, Luca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Ghrelin antagonists; Ghrelin receptor inhibitors; Growth hormone secretagogue receptor antagonists; Obesity

Indexed keywords

GHRELIN RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL STRAIN HEK293; FOOD INTAKE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OBESITY; PATENT; WEIGHT GAIN;

ANIMALS; ANTI-OBESITY AGENTS; DRUG DESIGN; EATING; FEMALE; HEK293 CELLS; HORMONE ANTAGONISTS; HUMANS; MOLECULAR STRUCTURE; PATENTS AS TOPIC; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; WEIGHT GAIN;

EID: 84862285219     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2012.684946     Document Type: Article

References (17)

1. Costantino L, Barlocco D.Ghrelin receptor modulators and their therapeutic potential.Future Med Chem 2009;1:157-77
2. Ozawa A, Speaker RB, Lindberg I.Enzymatic characterization of a human acyltransferase activity.PLoS One 2009;4:e5426
3. Dale JW, Hollingworth GJ, McKenna JM.Developments and advances in gastrointestinal prokinetic agents.Ann Rep Med Chem 2011;46:135-54
4. Sallam HS, Chen JDZ.The prokinetic face of ghrelin.Int J Pept 2010; article ID 493614
5. Hoveyda HR, Marsault E, Gagnon R, et al.Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of Ulimorelin (TZP-101) from hit to clinic.J Med Chem 2011;54:8305-20
6. Hanrahan P, Bell J, Bottomley G, et al.Substituted azaquinazolinones as modulators of GHSR-1a for the treatment of type II diabetes and obesity.Bioorg Med Chem Lett 2012;22:2271-8
7. Mihalic JT, Kim YJ, Lizarzaburu M, et al.Discovery of a new class of ghrelin receptor antagonists.Bioorg Med Chem Lett 2012;22:2046-51
8. Costantini VJA, Vicentini E, Sabbatini FM, et al.GSK 1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs.Neuroendocrinology 2011;94:158-68
9. Sabbatini FM, Melotto S, Bernasconi G, et al.Azabicyclo[3.1.0]hexane-1- carbohydrazides as potent and selective GHSR1a ligand presenting a specific in vivo behavior.ChemMedChem 2011;6:1981-5
10. Moulin A, Demange L, Ryan J, et al.New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists.3.Synthesis and pharmacological in vitro and in vivo evaluations.J Med Chem 2008;51:689-93
11. Moulin A, Demange L, Berge G, et al.Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure.2.synthesis and pharmacological in vitro and in vivo evaluations.J Med Chem 2007;50:5790-806
12. Barnett BP, Hwang Y, Taylor MS, et al.Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor.Science 2010;330:1689-92
13. Growth hormone secretagogue receptor antagonists.WO2011159917A2; 2011
14. Dodge JA, Heiman ML.Ghrelin receptor modulators.Ann Rep Med Chem 2003;38:81-8
15. Costantino L.Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase as porential therapeutic agents for obesity and diabetes.Exp Opin Ther Patents 2010;20:1603-7
16. Pralmorelin.Drugs Future 2005;30:124-7
17. Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.Drugs R D 2004;5:236-9